Efficacy of Fasting Glucose-Leptin Ratio as a Risk Marker for Development of Long Term Diabetic Complications

International Journal of Clinical Chemistry and Laboratory Medicine
doi 10.20431/2455-7153.0501003
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

ARC Publications Pvt Ltd.

Related search

Long-Term Absolute Risk for Cardiovascular Disease Stratified by Fasting Glucose Level

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2019English

Long-Term Complications of Diabetes and the Risk of Diabetic Foot

Health Problems of Civilization
2018English

Serum Magnesium as a Marker of Diabetic Complications

Journal of Evolution of Medical and Dental Sciences
2012English

PAPP-A as a Marker of Increased Long-Term Risk in Patients With Chest Pain

Clinical Biochemistry
MedicineClinical Biochemistry
2009English

Mitogen-Activated Protein Kinases as Glucose Transducers for Diabetic Complications

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1999English

Long-Term Efficacy of Tonsillectomy as a Treatment for IgA Nephropathy

Journal of Japan Society of Immunology & Allergology in Otolaryngology
2018English

Self-Harm Thoughts Postpartum as a Marker for Long-Term Morbidity

Frontiers in Public Health
EnvironmentalPublic HealthOccupational Health
2018English

Risk Factors for Development of Pre-Diabetic State From Normal Glucose Regulation

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2006English

Loss of Beta Cell Function as Fasting Glucose Increases in the Non-Diabetic Range

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy